Get that toothpaste back in the tube!
Attendees at an American Diabetes Association meeting on Monday were treated to exclusive information that had the potential to move markets, but the presenters asked that no one share it, in particular, on Twitter, according to Bloomberg. You might be able to guess how well that went, and soon the association was tweeting to those sharing to “Please delete immediately,” the article states. The info concerning Novo Nordisk A/S’ diabetes treatment Victoza apparently wasn’t good news for the company, because shares in Novo Nordisk fell 5.6 percent the next day. Feel free to tweet this as you see fit.
Facebook: A New Advocate for Mental Health?
Facebook user, Carrie Simmons, noticed a post from an old friend she thought read like a suicide note, “Thank you for everyone who tried to help me,”the post said — she called police, who found the friend in his car with a gun in his lap, unharmed, a Seattle Times article notes. The social media site with more than 1.65 billion users has developed a suicide-prevention tool that lets people flag friends’ posts they believe to be suicidal. Those posts are marked urgent and fed to Facebook community operations teams. If the post is considered a cry for help, the person who posted the message is given help lines and suicide-prevention resources the next time they log on to Facebook, according to the Times. With suicide rates at a 30-year high, the report says, the large Facebook user-base may be a good place for intervention.
Can Vermont Law Expose Pharma Price Hikes?
With a new law in effect, the green mountain state becomes the first to require drug makers to justify price hikes for medicines, “STAT” reports. The law orders state officials to ID 15 drugs for which, “significant health care dollars,”(whatever that means) are spent, and where wholesale acquisition costs jumped by 50 percent or more over the previous five-year timespan, the report states. A state attorney must then reach out to drug makers for justification for the hikes and pharma companies must submit a breakdown of factors concerning the increases in price — violations cost $10,000. The reports would be made public, but won’t allow us to shake our fists in anger at any one company because specific drugs and company names won’t be released, “STAT” unfortunately reports.
AMA Tackles Opioids With New Tools
The American Medical Association announced new policies to help slow the opioid epidemic that’s killing 78 people each day. The policies encourage physicians to co-prescribe naloxone to patients at risk of an overdose; promote timely and appropriate access to alternative non-opioid treatments for pain; and end support for health care facilities receiving payment for patients satisfaction scores tied to pain evaluations, according to an AMA press release. “These new policies build on the work of our task force, which has made clear that physicians must take a leading role in reversing the tide of this epidemic,” said Patrice Harris, M.D. and chair-elect of the AMA and chair of the association’s task for on opioids in the release.